CA946374A - 17.beta.-HYDROXY-17.alpha.-(2'-METHALLYL)9.beta.,10.alpha.-ANDROSTA-1,4,6-TRIEN-3-ONE, METHODS OF PRODUCING THIS COMPOUND AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPOUND AS AN ACTIVE INGREDIENT - Google Patents
17.beta.-HYDROXY-17.alpha.-(2'-METHALLYL)9.beta.,10.alpha.-ANDROSTA-1,4,6-TRIEN-3-ONE, METHODS OF PRODUCING THIS COMPOUND AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPOUND AS AN ACTIVE INGREDIENTInfo
- Publication number
- CA946374A CA946374A CA087,965A CA87965A CA946374A CA 946374 A CA946374 A CA 946374A CA 87965 A CA87965 A CA 87965A CA 946374 A CA946374 A CA 946374A
- Authority
- CA
- Canada
- Prior art keywords
- beta
- alpha
- compound
- androsta
- trien
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 title 2
- 239000004480 active ingredient Substances 0.000 title 1
- 239000008194 pharmaceutical composition Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3586169 | 1969-07-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA946374A true CA946374A (en) | 1974-04-30 |
Family
ID=10382363
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA087,965A Expired CA946374A (en) | 1969-07-16 | 1970-07-13 | 17.beta.-HYDROXY-17.alpha.-(2'-METHALLYL)9.beta.,10.alpha.-ANDROSTA-1,4,6-TRIEN-3-ONE, METHODS OF PRODUCING THIS COMPOUND AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPOUND AS AN ACTIVE INGREDIENT |
Country Status (13)
Country | Link |
---|---|
US (1) | US3723482A (fr) |
JP (2) | JPS4813540B1 (fr) |
BE (1) | BE753458A (fr) |
CA (1) | CA946374A (fr) |
CH (2) | CH542832A (fr) |
DE (1) | DE2034333A1 (fr) |
ES (1) | ES381764A1 (fr) |
FR (1) | FR2059516B1 (fr) |
GB (1) | GB1266361A (fr) |
IL (1) | IL34910A (fr) |
NL (1) | NL7010302A (fr) |
SE (1) | SE362643B (fr) |
ZA (1) | ZA704380B (fr) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH428720A (de) * | 1958-04-12 | 1967-01-31 | Philips Nv | Verfahren zur Herstellung neuer Steroide |
GB1012794A (en) * | 1962-05-11 | 1965-12-08 | Thomas Dudley Threadgold | New steroids and methods of producing same |
US3198792A (en) * | 1962-06-12 | 1965-08-03 | Philips Corp | 10alpha methyl, 9beta hormonal steroids |
BE667121A (fr) * | 1964-10-28 |
-
1969
- 1969-07-16 GB GB3586169A patent/GB1266361A/en not_active Expired
-
1970
- 1970-06-25 ZA ZA704380A patent/ZA704380B/xx unknown
- 1970-07-10 DE DE19702034333 patent/DE2034333A1/de active Pending
- 1970-07-11 NL NL7010302A patent/NL7010302A/xx unknown
- 1970-07-13 CA CA087,965A patent/CA946374A/en not_active Expired
- 1970-07-13 CH CH644773A patent/CH542832A/de not_active IP Right Cessation
- 1970-07-13 SE SE09709/70A patent/SE362643B/xx unknown
- 1970-07-13 CH CH1061470A patent/CH540238A/de not_active IP Right Cessation
- 1970-07-13 IL IL34910A patent/IL34910A/en unknown
- 1970-07-13 US US00054616A patent/US3723482A/en not_active Expired - Lifetime
- 1970-07-13 JP JP45060701A patent/JPS4813540B1/ja active Pending
- 1970-07-14 BE BE753458D patent/BE753458A/fr unknown
- 1970-07-14 ES ES381764A patent/ES381764A1/es not_active Expired
- 1970-07-15 FR FR707025996A patent/FR2059516B1/fr not_active Expired
-
1971
- 1971-12-24 JP JP46104739A patent/JPS4813541B1/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE2034333A1 (de) | 1971-01-28 |
JPS4813541B1 (fr) | 1973-04-27 |
BE753458A (fr) | 1971-01-14 |
IL34910A0 (en) | 1970-09-17 |
ZA704380B (en) | 1972-02-23 |
FR2059516A1 (fr) | 1971-06-04 |
CH540238A (de) | 1973-08-15 |
CH542832A (de) | 1973-11-30 |
SE362643B (fr) | 1973-12-17 |
GB1266361A (fr) | 1972-03-08 |
US3723482A (en) | 1973-03-27 |
IL34910A (en) | 1973-06-29 |
FR2059516B1 (fr) | 1973-06-08 |
ES381764A1 (es) | 1973-04-16 |
NL7010302A (fr) | 1971-01-19 |
JPS4813540B1 (fr) | 1973-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA927394A (en) | Substituted guanidines, compositions and method of preparation | |
CA968273A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING M-TYROSINE AND .alpha.-HYDRAZINO-3,4-DIHYDROXYPHENYLPROPIONIC ACID | |
CA946374A (en) | 17.beta.-HYDROXY-17.alpha.-(2'-METHALLYL)9.beta.,10.alpha.-ANDROSTA-1,4,6-TRIEN-3-ONE, METHODS OF PRODUCING THIS COMPOUND AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPOUND AS AN ACTIVE INGREDIENT | |
CA1008461A (en) | 3,4-dihydroxyphenyl-alamines as active ingredients of antioxidant compositions | |
CA960655A (en) | N(6)-aralkyl adenosine derivatives, process for their preparation and pharmaceutical compositions containing the same | |
AU471022B2 (en) | Pharmaceutical compositions containing 3-hydroxy-5-pregnane 11, 2-dione | |
CA945544A (en) | 16-METHYLENE-9.beta., 10.alpha.-STEROID COMPOUNDS, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN THE NOVEL COMPOUNDS AS ACTIVE INGREDIENTS, AND METHODS OF PRODUCING THE SAID COMPOUNDSAND PREPARATIONS | |
CA815003A (en) | 9.beta., 10.alpha.-STEROIDS, METHODS OF PRODUCING THESE PRODUCTS, INTERMEDIATES THEREFORE AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE NEW COMPOUNDS AS AN ACTIVE INGREDIENT | |
CA931953A (en) | 2,(2',6'-dichlorophenyl)1,3-thiazine-4-one, methods of producing the said substance and preparations containing it as an active ingredient | |
CA874437A (en) | 18-METHYL-9.beta.,10.alpha.-STEROIDS OF THE ANDROSTANE SERIES, METHODS OF PRODUCING THE SAME, PHARMACEUTICAL PREPARATIONS CONTAINING SAID COMPOUNDS AS ACTIVE INGREDIENTS AND METHODS OF PRODUCING THE SAID PREPARATIONS | |
CA953715A (en) | N(6)-(2,5-dimethylbenzyl)-2-chloroadenosine derivatives, process for their preparation and pharmaceutical compositions containing the same | |
CA807142A (en) | 9.beta.,10.alpha.-STEROIDS, METHODS OF PRODUCING THE SAME, PHARMACEUTIC PREPARATIONS CONTAINING SAID 9.beta.,10.alpha.-STEROIDS AS ACTIVE SUBSTANCES AND METHODS OF PRODUCING SAID PREPARATIONS | |
NL139239B (nl) | Werkwijze voor de bereiding van anti-inflammatoire en analgetische preparaten, die als werkzame verbinding 1,2-difenyl-4-gesubstitueerde pyrazolidinedionen-3,5 bevatten, aldus verkregen gevormde preparaten, en werkwijze voor de bereiding van de daarin toegepaste actieve verbindingen. | |
CA769021A (en) | 9.beta.,10.alpha.-STEROIDS, METHODS OF PRODUCING SAID COMPOUNDS AND METHODS OF PRODUCING PHARMACEUTIC PREPARATIONS CONTAINING SAID COMPOUNDS AS ACTIVE CONSTITUENTS AND SAID PREPARATIONS | |
CA851190A (en) | Sulphonyl-ureas and sulphonyl-semicarbazides, preparation thereof and pharmaceutical compositions | |
CA776679A (en) | Urazole compounds, pharmaceutical compositions containing same, and process of administering same | |
CA838088A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING 5((.alpha.,.alpha.,.alpha.,-TRIFLUORO-M-TOLYLOXY)-METHYL)-2-OXAZOLIDINETHIONE | |
CA937929A (en) | PREPARATION OF 5.alpha.-PREGNANE-16.alpha.-ACYLAMIDO-3.beta.,17.alpha.-DIOL-11,20-DIOANE-3-ACYLATES | |
CA819719A (en) | 17.beta.-HALO-16.alpha.-(2-OXOALKYL)-17-ISOPREGNANES AND PREPARATION THEREOF | |
AU425534B2 (en) | Novel gona-4, 9, 11-trienes, processes for their preparation, and pharmaceutical compositions incorporating them | |
AU449767B2 (en) | New acetamidines, processes for their preparation, and pharmaceutical compositions incorporating same | |
CA827661A (en) | PROCESS FOR THE PREPARATION OF 17-SUBSTITUTED-10.beta.-METHYL-D-HOMO-C-NOR-5.alpha.,13.alpha.-GONAN-3-ONES AND POLYDEHYDRO DERIVATIVES THEREOF | |
CA844580A (en) | Pharmaceutical compositions having central activity | |
AU454701B2 (en) | New urea derivatives, a method of producing them and preparations which contain the new substances as active ingredients | |
AU273358B2 (en) | 6, 7-benzmorphan derivatives and pharmaceutical compositions containing thesame |